Mirion Technologies Inc. (NYSE: MIR) bucked the broader market trend on Wednesday, closing 1.1% higher at $18.24. The gain came even as major U.S. indexes declined, highlighting investor focus on the company's nuclear safety business following recent strategic announcements.
The stock traded between $17.91 and $18.65 during the session, with volume reaching approximately 4.64 million shares—above the 4.24 million average. After-hours trading saw the stock hold steady at $18.25.
The broader market weakened as the S&P 500 fell 0.74%, the Dow Jones Industrial Average slid 1.21%, and the Nasdaq Composite lost 0.89%. Rising oil prices and a pullback from recent record highs contributed to the risk-off sentiment. Wasif Latif, chief investment officer at Sarmaya Partners, described the move as the market “taking a breather.”
Mirion's relative strength stems from developments in its nuclear franchise. On June 2, the company announced a memorandum of understanding with the University of Liverpool to expand collaboration on nuclear science, radiation protection, and other strategic technologies. This marks Mirion's first such agreement with a UK university. James Cocks, chief technology officer, stated, “There is no path to advancing nuclear capability without strong collaboration.”
Additionally, Tighe Smith, Mirion's chief nuclear officer and also chief nuclear officer at Paragon Energy Solutions, received an American Nuclear Society Presidential Citation at the society's annual meeting. Smith oversees global nuclear strategy for both entities.
First-quarter results, reported for the April period, showed revenue of $257.6 million, up 27.5% year-over-year. Orders rose 19% excluding contributions from Paragon and Certrec. Adjusted EBITDA increased 16.3% to $54.3 million. CEO Thomas Logan highlighted “substantial orders growth led by nuclear power demand.”
However, the company posted a GAAP net loss of $3.4 million and lowered its adjusted EPS guidance to $0.48-$0.55 from $0.50-$0.57, citing a one-time retention grant for its CEO. The mixed earnings picture tempers the bullish narrative, as investors weigh the potential for nuclear orders to translate into sustainable cash flow.
Among peers in the instrumentation and scientific equipment space, performance was mixed. Thermo Fisher Scientific fell 1.7%, Teledyne Technologies edged down 0.1%, while Ametek gained 0.3%. This suggests Mirion's move was company-specific rather than sector-wide.
Looking ahead, the key question is whether Mirion's nuclear safety momentum can convert order growth into improved margins, or if macroeconomic headwinds—such as higher interest rates and oil-driven inflation—will pressure smaller industrial stocks. For now, the stock's ability to rally against a weak tape underscores investor conviction in its nuclear-focused strategy.
